{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T00:46:08Z","timestamp":1785631568615,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant disorder arising from mutations of the MEN1 tumor suppressor gene on chromosome 11q13; MEN1 is characterized by the development of neuroendocrine tumors, including those of the parathyroid, gastrointestinal endocrine tissue and anterior pituitary. Additionally, thymic neuroendocrine tumors in MEN1 are also rarely reported.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>This case report observed a family that presented with MEN1 p.L105Vfs mutation, and two of the family members had been diagnosed with thymic neuroendocrine tumor combined with MEN1. To the best of our knowledge, this is the first time such a mutation in the MEN1 gene has been reported. The proband presented with thymic neuroendocrine tumor, parathyroid adenoma and rectum adenocarcinoma. The son of the proband presented with thymic neuroendocrine tumor, gastrinoma, hypophysoma and parathyroid adenoma. Genetic testing revealed the frameshift mutation p.L105Vfs, leading to the identification of one carrier in the pedigree (the patient\u2019s younger sister). The proband then underwent parathyroidectomy at the age of 26\u2009years (in 1980) for a parathyroid adenoma. Subsequently, the patient underwent thymectomy, radiotherapy and chemotherapy. The patient is now 64\u2009years old, still alive and still undergoing Lanreotide therapy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Thymic neuroendocrine MEN1 is rare, but it accounts for almost 20% of MEN1-associated mortality. Consequently, we should focus on regular clinical screening of the thymus in MEN1 patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-020-01659-7","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:02:36Z","timestamp":1583312556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Hongjuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanfen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"issue":"1","key":"1659_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2265.2009.03662.x","volume":"72","author":"J Burgess","year":"2010","unstructured":"Burgess J. How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol. 2010;72(1):13\u20136. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03662.x PubMed PMID: 19552677.","journal-title":"Clin Endocrinol"},{"key":"1659_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1172-1-38","volume":"1","author":"F Marini","year":"2006","unstructured":"Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis. 2006;1:38. https:\/\/doi.org\/10.1186\/1750-1172-1-38 PubMed PMID: 17014705; PubMed Central PMCID: PMCPMC1594566.","journal-title":"Orphanet J Rare Dis"},{"issue":"5311","key":"1659_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.276.5311.404","volume":"276","author":"SC Chandrasekharappa","year":"1997","unstructured":"Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276(5311):404\u20137. https:\/\/doi.org\/10.1126\/science.276.5311.404 PubMed PMID: 9103196.","journal-title":"Science."},{"issue":"1","key":"1659_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00000658-199807000-00015","volume":"228","author":"BT Teh","year":"1998","unstructured":"Teh BT, Zedenius J, Kytola S, Skogseid B, Trotter J, Choplin H, et al. Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg. 1998;228(1):99\u2013105 Epub 1998\/07\/22. PubMed PMID: 9671073; PubMed Central PMCID: PMCPMC1191434.","journal-title":"Ann Surg"},{"issue":"10","key":"1659_CR5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, et al. The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. J Thorac Oncol. 2015;10(10):1383\u201395. https:\/\/doi.org\/10.1097\/JTO.0000000000000654 PubMed PMID: 26295375; PubMed Central PMCID: PMCPMC4581965.","journal-title":"J Thorac Oncol"},{"issue":"9","key":"1659_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, Thymus, and heart. J Thorac Oncol. 2015;10(9):1240\u20132. https:\/\/doi.org\/10.1097\/JTO.0000000000000663 PubMed PMID: 26291007.","journal-title":"J Thorac Oncol"},{"issue":"8","key":"1659_CR7","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.jtho.2019.04.015","volume":"14","author":"H Dinter","year":"2019","unstructured":"Dinter H, Bohnenberger H, Beck J, Bornemann-Kolatzki K, Schutz E, Kuffer S, et al. Molecular classification of neuroendocrine tumors of the Thymus. J Thorac Oncol. 2019;14(8):1472\u201383. https:\/\/doi.org\/10.1016\/j.jtho.2019.04.015 PubMed PMID: 31042566.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"1659_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF02662474","volume":"54","author":"Y Kojima","year":"2006","unstructured":"Kojima Y, Ito H, Hasegawa S, Sasaki T, Inui K. Resected invasive thymoma with multiple endocrine neoplasia type 1. Jpn J Thorac Cardiovasc Surg. 2006;54(4):171\u20133. https:\/\/doi.org\/10.1007\/BF02662474 Epub 2006\/04\/29. PubMed PMID: 16642925.","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"issue":"6","key":"1659_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4158\/EP.14.6.713","volume":"14","author":"BS Miller","year":"2008","unstructured":"Miller BS, Rusinko RY, Fowler L. Synchronous thymoma and thymic carcinoid in a woman with multiple endocrine neoplasia type 1: case report and review. Endocr Pract. 2008;14(6):713\u20136. https:\/\/doi.org\/10.4158\/EP.14.6.713 PubMed PMID: 18996790 Epub 2008\/11\/11.","journal-title":"Endocr Pract"},{"issue":"4","key":"1659_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","volume":"76","author":"A Sakurai","year":"2012","unstructured":"Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, et al. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol. 2012;76(4):533\u20139. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04227.x Epub 2011\/09\/29. PubMed PMID: 21950691.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"1659_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1365-2796.1998.00275.x","volume":"243","author":"JR Burgess","year":"1998","unstructured":"Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med. 1998;243(6):465\u201370 Epub 1998\/07\/29. PubMed PMID: 9681844.","journal-title":"J Intern Med"},{"issue":"1","key":"1659_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/EJE-10-0950","volume":"165","author":"P Goudet","year":"2011","unstructured":"Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Menegaux F, et al. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs endocrines. Eur J Endocrinol. 2011;165(1):97\u2013105. https:\/\/doi.org\/10.1530\/EJE-10-0950 Epub 2011\/05\/10. PubMed PMID: 21551167.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1659_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat. 2008;29(1):22\u201332. https:\/\/doi.org\/10.1002\/humu.20605 Epub 2007\/09\/20. PubMed PMID: 17879353.","journal-title":"Hum Mutat"},{"issue":"6","key":"1659_CR14","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00268-009-9980-y","volume":"33","author":"P Goudet","year":"2009","unstructured":"Goudet P, Murat A, Cardot-Bauters C, Emy P, Baudin E, du Boullay CH, et al. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs endocrines). World J Surg. 2009;33(6):1197\u2013207. https:\/\/doi.org\/10.1007\/s00268-009-9980-y Epub 2009\/03\/19. PubMed PMID: 19294466.","journal-title":"World J Surg"},{"issue":"1","key":"1659_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00005792-199701000-00002","volume":"76","author":"BT Teh","year":"1997","unstructured":"Teh BT, McArdle J, Chan SP, Menon J, Hartley L, Pullan P, et al. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine (Baltimore). 1997;76(1):21\u20139 Epub 1997\/01\/01. PubMed PMID: 9064485.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1659_CR16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cen.13480","volume":"87","author":"L Ye","year":"2017","unstructured":"Ye L, Wang W, Ospina NS, Jiang L, Christakis I, Lu J, et al. Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-Centre study, systematic review and meta-analysis. Clin Endocrinol. 2017;87(6):706\u201316. https:\/\/doi.org\/10.1111\/cen.13480 Epub 2017\/09\/25. PubMed PMID: 28940393.","journal-title":"Clin Endocrinol"},{"issue":"9","key":"1659_CR17","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230 PubMed PMID: 22723327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1659_CR18","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1210\/jc.2004-1155","volume":"90","author":"P Ferolla","year":"2005","unstructured":"Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab. 2005;90(5):2603\u20139. https:\/\/doi.org\/10.1210\/jc.2004-1155 Epub 2005\/02\/17. PubMed PMID: 15713725.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1659_CR19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/jc.2002-021314","volume":"88","author":"F Gibril","year":"2003","unstructured":"Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88(3):1066\u201381. https:\/\/doi.org\/10.1210\/jc.2002-021314 Epub 2003\/03\/12. PubMed PMID: 12629087.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1659_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/35101031","volume":"1","author":"AG Knudson","year":"2001","unstructured":"Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer. 2001;1(2):157\u201362. https:\/\/doi.org\/10.1038\/35101031 PubMed PMID: 11905807.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1659_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/jnnp.53.7.624","volume":"53","author":"LJ Vroegindeweij-Claessens","year":"1990","unstructured":"Vroegindeweij-Claessens LJ, Tijssen CC, Creemers GJ, Lockefeer JH, Teepen JL. Myasthenia gravis and thymoma in multiple endocrine neoplasia (MEN-1) syndrome. J Neurol Neurosurg Psychiatry. 1990;53(7):624\u20135 Epub 1990\/07\/01. PubMed PMID: 1975268; PubMed Central PMCID: PMCPMC488149.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1659_CR22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1677\/ERC-07-0015","volume":"14","author":"XH Jiang","year":"2007","unstructured":"Jiang XH, Lu JL, Cui B, Zhao YJ, Wang WQ, Liu JM, et al. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1. Endocr Relat Cancer. 2007;14(4):1073\u20139. https:\/\/doi.org\/10.1677\/ERC-07-0015 Epub 2007\/11\/30. PubMed PMID: 18045958.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"1659_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/gut.2006.108910","volume":"56","author":"M Anlauf","year":"2007","unstructured":"Anlauf M, Perren A, Henopp T, Rudolf T, Garbrecht N, Schmitt A, et al. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions. Gut. 2007;56(5):637\u201344. https:\/\/doi.org\/10.1136\/gut.2006.108910 PubMed PMID: 17135306; PubMed Central PMCID: PMCPMC1942169.","journal-title":"Gut"},{"issue":"5","key":"1659_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/gut.2006.113985","volume":"56","author":"DM Pritchard","year":"2007","unstructured":"Pritchard DM. Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1. Gut. 2007;56(5):606\u20137. https:\/\/doi.org\/10.1136\/gut.2006.113985 PubMed PMID: 17440178; PubMed Central PMCID: PMCPMC1942163.","journal-title":"Gut"},{"issue":"6","key":"1659_CR25","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1210\/jcem.87.6.8607","volume":"87","author":"JJ Turner","year":"2002","unstructured":"Turner JJ, Leotlela PD, Pannett AA, Forbes SA, Bassett JH, Harding B, et al. Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2002;87(6):2688\u201393. https:\/\/doi.org\/10.1210\/jcem.87.6.8607 Epub 2002\/06\/07. PubMed PMID: 12050235.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1659_CR26","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1073\/pnas.98.3.1118","volume":"98","author":"JS Crabtree","year":"2001","unstructured":"Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A. 2001;98(3):1118\u201323. https:\/\/doi.org\/10.1073\/pnas.98.3.1118 Epub 2001\/02\/07. PubMed PMID: 11158604; PubMed Central PMCID: PMCPMC14718.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"1659_CR27","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1038\/sj.onc.1209400","volume":"25","author":"P La","year":"2006","unstructured":"La P, Desmond A, Hou Z, Silva AC, Schnepp RW, Hua X. Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression. Oncogene. 2006;25(25):3537\u201346. https:\/\/doi.org\/10.1038\/sj.onc.1209400 Epub 2006\/02\/02. PubMed PMID: 16449969.","journal-title":"Oncogene."},{"issue":"47","key":"1659_CR28","doi-asserted-by":"publisher","first-page":"49045","DOI":"10.1074\/jbc","volume":"279","author":"P La","year":"2004","unstructured":"La P, Silva AC, Hou Z, Wang H, Schnepp RW, Yan N, et al. Direct binding of DNA by tumor suppressor menin. J Biol Chem. 2004;279(47):49045\u201354. https:\/\/doi.org\/10.1074\/jbc Epub 2004\/08\/28. M409358200. PubMed PMID: 15331604; PubMed Central PMCID: PMCPMC2858586.","journal-title":"J Biol Chem"},{"issue":"2","key":"1659_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","volume":"34","author":"P Goudet","year":"2010","unstructured":"Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs endocrines) cohort study among 758 patients. World J Surg. 2010;34(2):249\u201355. https:\/\/doi.org\/10.1007\/s00268-009-0290-1 Epub 2009\/12\/02. PubMed PMID: 19949948.","journal-title":"World J Surg"},{"issue":"Suppl 5","key":"1659_CR30","doi-asserted-by":"publisher","first-page":"v220","DOI":"10.1093\/annonc\/mdq191","volume":"21","author":"K Oberg","year":"2010","unstructured":"Oberg K, Hellman P, Kwekkeboom D, Jelic S, Group EGW. Neuroendocrine bronchial and thymic tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v220\u20132. https:\/\/doi.org\/10.1093\/annonc\/mdq191 PubMed PMID: 20555085.","journal-title":"Ann Oncol"},{"issue":"4","key":"1659_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000486096","volume":"106","author":"WT Zandee","year":"2018","unstructured":"Zandee WT, de Herder WW. The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines. Neuroendocrinol. 2018;106(4):357\u201365. https:\/\/doi.org\/10.1159\/000486096 PubMed PMID: 29320780; PubMed Central PMCID: PMCPMC6067804.","journal-title":"Neuroendocrinol"},{"issue":"6","key":"1659_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.6004\/jnccn.2018.0056","volume":"16","author":"MH Shah","year":"2018","unstructured":"Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, et al. NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018. J Natl Compr Cancer Netw. 2018;16(6):693\u2013702. https:\/\/doi.org\/10.6004\/jnccn.2018.0056 PubMed PMID: 29891520.","journal-title":"J Natl Compr Cancer Netw"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-020-01659-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:15:33Z","timestamp":1614816933000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01659-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1659"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01659-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"27 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of Jinhua Hospital affiliated with Zhejiang University (Zhejiang, China). Written informed consent was obtained from the proband, his son and his relatives prior to genetic testing. All clinical investigations were conducted in accordance with the principles expressed in the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from the patient. And written consent for publication was also obtained from the proband\u2019s son and his relatives prior to genetic testing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}